Ovulatory Dysfunction Treatment in Malaysia

• Clinical assessment:
  • Menstrual and Reproductive History: The clinician evaluates menstrual-cycle length and regularity, duration of irregularity, bleeding pattern, symptoms suggesting ovulation, previous pregnancies, fertility history, contraceptive use, weight changes, exercise habits, stress, medications, and relevant medical conditions.
  • Hormonal and Endocrine Assessment: Blood tests may include thyroid-stimulating hormone (TSH), prolactin, follicle-stimulating hormone (FSH), estradiol, and other hormone tests according to the clinical presentation.
  • Assessment of Ovulation: Ovulation may be evaluated using menstrual-cycle information, urinary luteinizing hormone testing, serum progesterone measurement at an appropriate point in the cycle, or ultrasound-based follicular monitoring.
  • Assessment of Associated Conditions: Evaluation may include assessment for PMOS, thyroid disease, hyperprolactinemia, primary ovarian insufficiency, metabolic abnormalities, and other endocrine or systemic conditions that may interfere with ovulation.
  • Fertility Assessment: When pregnancy is desired, evaluation may also include assessment of fallopian-tube patency and semen analysis of the partner because infertility can result from female, male, combined, or unexplained factors.
• Imaging Tests:
  • Pelvic Ultrasound: Transvaginal ultrasound can evaluate the uterus and ovaries and may identify features associated with PMOS, ovarian cysts, or other pelvic abnormalities.
  • Follicular Monitoring: Serial ultrasound examinations can monitor follicular growth and help determine whether and when ovulation occurs during fertility treatment.
  • Ovarian Reserve Assessment: Ultrasound assessment of antral follicle count may be used with laboratory tests when ovarian reserve evaluation is clinically indicated.
  • Pituitary MRI: Consider pituitary MRI when laboratory findings or symptoms suggest a pituitary disorder, such as significant hyperprolactinemia.
  • Additional Imaging: Other imaging investigations may be performed when an underlying pelvic, endocrine, or structural condition is suspected.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support patients with ovulatory dysfunction in Malaysia. These Services include:

• Healthy Physical Activity: Regular, appropriately balanced physical activity can support metabolic health while avoiding excessive exercise that may interfere with reproductive function.
• Stress and Lifestyle Management: Adequate sleep, stress management, and avoidance of extreme dieting or excessive physical training may support reproductive health.
• Nutrition and Weight Management: A balanced diet and individualised nutritional support may help address contributing factors such as inadequate energy intake or weight-related metabolic concerns.
• Fertility Support: Patients undergoing ovulation induction or assisted reproduction may benefit from structured monitoring, counselling, and education about treatment schedules and fertility awareness.
• Long-Term Follow-Up: Continued gynecological or endocrinological follow-up may be needed to monitor menstrual patterns, treatment response, metabolic health, and recurrence of ovulatory dysfunction.

• Medicines are selected according to the cause of ovulatory dysfunction and whether pregnancy is desired. Gonadotropins may be used for selected patients requiring injectable ovarian stimulation. When ovulatory dysfunction is related to thyroid disease or hyperprolactinemia, treatment is directed toward the underlying hormonal disorder. When pregnancy is not desired, hormonal treatment may be considered to regulate menstrual bleeding and protect the uterine lining in selected patients. Treatment and monitoring depend on the diagnosis and individual needs.